Mycosis fungoides and Sezary Syndrome: An update

被引:15
作者
Kim E.J. [1 ]
Lin J. [1 ]
Junkins-Hopkins J.M. [1 ]
Vittorio C.C. [1 ]
Rook A.H. [1 ]
机构
[1] Department of Dermatology, University of Pennsylvania Health System, Philadelphia, PA 19104
关键词
Dermatol; Mycosis Fungoides; Bexarotene; Sezary Syndrome; Denileukin Diftitox;
D O I
10.1007/s11912-006-0061-1
中图分类号
学科分类号
摘要
Mycosis fungoides (MF), and the associated leukemic variant Sezary Syndrome (SS), are the most common group of cutaneous T-cell lymphomas. MF/SS is a non-Hodgkin's lymphoma of mature, skin-homing, clonal, malignant T lymphocytes that initially presents in the skin as patches, plaques, tumors, or generalized erythema (erythroderma) and can involve the lymph nodes and peripheral blood. Much progress has been made in recent years in understanding the origin of the malignant T cell in MF/ SS and the pathophysiology and immunology of the disease. This recent work has made a great impact on diagnosis, prognostication, and treatment. In this review, we survey the MF/SS published literature over the past year and highlight some of the important advances. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:376 / 386
页数:10
相关论文
共 69 条
[1]  
Girardi M., Heald P.W., Wilson L.D., The pathogenesis of mycosis fungoides, N Engl J Med, 35, pp. 1978-1988, (2004)
[2]  
WHO-EORTC classification for cutaneous lymphomas, Blood, 105, pp. 3768-3785, (2005)
[3]  
Pimpinelli N., Olsen E.A., Santucci M., Et al., Defining early mycosis fungoides, J Am Acad Dermatol, 53, pp. 1053-1063, (2005)
[4]  
Wood G.S., Tung R.M., Haeffner A.C., Et al., Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE), J Invest Dermatol, 103, pp. 34-41, (1994)
[5]  
Ponti R., Quaglino P., Novelli M., Et al., T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings, Br J Dermatol, 153, pp. 565-573, (2005)
[6]  
Alessi E., Coggi A., Venegoni L., Et al., The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma, Br J Dermatol, 153, pp. 368-371, (2005)
[7]  
Guitart J., Beyond clonal detection: Defining the T-cell clone, Arch Dermatol, 141, 9, pp. 1159-1160, (2005)
[8]  
Cordel N., Lenormand B., Courville P., Et al., Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma, Arch Pathol Lab Med, 129, pp. 372-376, (2005)
[9]  
Tracey L., Villuendas R., Dotor A.M., Et al., Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: An expression profile study, Blood, 102, pp. 1042-1050, (2003)
[10]  
Kari L., Loboda A., Nebozhyn M., Et al., Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma, J Exp Med, 197, pp. 1477-1488, (2003)